Conference

Keynote Fireside Discussion: Competitive Strategy & Sustained Innovation in Biotech

Showing Events in 1 Track from 08:30am to 10:00am

Keynotes

8:30AM - 9:00AM

Gary Pisano, PhD, Harry E Figgie, Jr Professor of Business Administration, Harvard Business School

Alex Snyder, MD, EVP, Research and Development, Generate Biomedicines

9:00AM - 9:30AM

R&D Leadership Keynote

Mathai Mammen, MD, PhD, CEO, President, and Chairman, FogPharma

Nerissa Kreher, MD, MBA, Consultant CMO/Board Member, Rezolute Bio

9:30AM - 10:00AM

Biotech Investment Banking Keynote Fireside Discussion with HC Wainwright's Vice Chairman, Head of M&A and Strategic Advisory Services

Michael Meyers, Vice Chairman & Head of M&A and Strategic Advisory Services, HC Wainwright & Co.

Grand Opening Break & Networking

Showing Events in 1 Track from 10:00am to 10:45am

Grand Opening Break & Networking

10:00AM - 10:45AM

Showing Events in 1 Track from 10:45am to 01:00pm

Day 1 Morning General Session Continued

10:45AM - 11:15AM

Veteran Perspectives to Pivoting as a CMO

Anna Frostegård, MD, PhD, Co-Founder, Chief Scientific & Medical Officer, Annexin Pharmaceuticals

Patrick Burnett, MD, PhD, CMO, Arcutis Biotherapeutics

Elliot Ehrich, MD, CMO, EVP, Translational Science, LifeMine Therapeutics

11:15AM - 11:30AM

When a Lethal Disease becomes Chronic: The Emergence of Patient Reported Outcomes in Oncology

Michael Murphy, MD, PhD, CMO / CSO, Worldwide Clinical Trials

11:30AM - 12:00PM

Managing and Motivating a Biotech Team in 2024

Joanne Lager, MD, CMO, NiKang Therapeutics

Donna Higgins, CEO, The Higgins Group

Oscar Segurado, MD, PhD, CMO, ASC Therapeutics

Amy Simon, MD, CMO, Beam Therapeutics

12:00PM - 12:15PM

A Quantitative Framework for Effective Patient-Centric Trial Design in Capital-Limited Environments

Scott Chetham, PhD, CEO and Co-Founder, Faro Health

12:15PM - 12:45PM

How to Create the Greatest Value Within a Budget Before the Next Funding Raise

Alessandra Cesano, MD, PhD, CMO, EVP, ESSA Pharma

Sofia Baig, President, Clinical Solutions, Precision for Medicine

Leonard Dragone, MD, PhD, CMO, Abata Therapeutics

Jeffrey Humphrey, MD, Founder, CEO, Charged Biotherapeutics

12:45PM - 1:00PM

Implement a Lean Methodology for More Efficient Clinical Trial Operations

Julie Martin, MSc, MBA, CEO & Co-Owner, Scimega Research

Showing Events in 1 Track from 01:00pm to 02:00pm

Lunch

1:00PM - 2:00PM

Lunch and Networking

Showing Events in 2 Tracks from 02:00pm to 03:30pm

Track A: Best Practices Managing CMO Departments (Ballroom Foyer)

How CMOs Build a Network of Consultants

Sonal Gupta, MD, PhD, SVP, Head of Clinical Development, AffyImmune Therapeutics

Carrie Brownstein, MD, CMO, CMB BioPharma Solutions LLC

Swaminathan Murugappan, MD, PhD, CMO, Trident Bio Consulting Inc.

Jen Seda, MD, Practice Lead & Senior Vice President, Medical, SSI Strategy

How Biotechs and CROs Navigate their Relationships to Advance Clinical Development

Roger Waltzman, MD, MBA, CMO, Indaptus Therapeutics

Danko Dominis, MD, PhD, VP, Global Medical Officer, Biotech Solutions, PPD, part of Thermo Fisher Scientific

Chuck Gelb, Chief Commercial Officer, Phastar

Judith Ng-Cashin, MD, Chief Medical Officer, Novotech

Edwin Rock, MD, PhD, CMO, GlycoMimetics

Patient Engagement: Practical Approaches

Kali Stasi, MD, PhD, SVP, Clinical Development, Adverum Biotechnologies, Inc.

Arun Balakumaran, MD, PhD, CMO, Replay Bio

Charlotte Guzzo, Co-Founder and COO, Sano Genetics

Wendy Harman, VP Product Marketing, Tasso, Inc.

Jessica Scott, MD, JD, CEO, Legacy Health Strategies

Track B: The Lifecycle of a Biotech CMO (Grand Ballroom)

CEOs’ Insights on Where CMOs can Best Add Value for Companies in Different Stages

James "Terry" Ferguson, MD, CMO, Matinas Biopharma

Laurent Audoly, PhD, Executive Partner, Apollo Health Ventures

Steve Kanes, MD, PhD, CEO, EmbarkNeuro

John Mumm, PhD, President & CEO, DEKA Biosciences

The CMO as a Translational Scientist

Joseph Elassal, MD, MBA, CMO, Ankyra Therapeutics

Panelist:

Steven Katz, MD, CMO, TriSalus Life Sciences

Andrea Wang-Gillam, MD, PhD, CMO, Jacobio Pharmaceuticals

Scaling Up Effectively as Your Biotech Company Evolves

Peter Francis, MD, PhD, CMO & CSO, Ray Therapeutics

Gurdyal Kalsi, MD, CMO, Asklepion Pharmaceuticals

James Lewis, Executive Director, Barrington James

Ajay Sadhwani, SVP of Operations, Harbor Clinical

Hunter Smith, Head of Clinical Recruitment, Govig & Associates

Showing Events in 1 Track from 03:30pm to 04:15pm

Afternoon Break & Networking

3:30PM - 4:15PM

Afternoon Break & Networking

Showing Events in 2 Tracks from 04:15pm to 05:15pm

Track A: Best Practices Managing CMO Departments (Ballroom Foyer)

Maximizing Regulatory Interactions

Simon Cooper, MBBS, CMO, Morphic Therapeutic

Vijay Kasturi, MD, CMO, CG Oncology

Giovanni Selvaggi, MD, CMO, Xcovery Holdings

Mark Sumeray, MD, CMO, Amolyt Pharma

What CMOs Need to Know about Partnering with Hospitals & Clinical Research Sites

Eric Feldman, MD, Director, Early Phase Clinical Trial Program, Montefiore Einstein Comprehensive Cancer Center

Bruce Dezube, MD, CMO, Mustang Bio

Serena Hung, MD, Former CMO, Arkuda Therapeutics

Karen Ivester, RN, MA, Executive Director, Operations, Oncology and Cell & Gene Therapy, inSeption Group

Manoj Malhotra, MD, CMO, Ovid Therapeutics

Track B: The Lifecycle of a Biotech CMO (Grand Ballroom)

Transitioning from Early Stage to Registrational/Pivotal Stage Development

Arvin Yang, MD, PhD, CMO, Pheon Therapeutics

Johan Baeck, MD, Executive Vice President & Chief Medical Officer, Promontory Therapeutics Inc.

Lise Kjems, MD, PhD, CMO, Ocelot Bio

May Orfali, MD, MBA, CMO, Harbinger Health

Preparing for Launch: What CMOs Need to Know and Do

John Yee, MD, MPH, Senior VP, Medical Affairs, Apnimed, Inc.

Peg Crowley-Nowick, PhD, MBA, President, Medical Affairs Consulting and Head of Medical Affairs, Lumanity

Lori Klein, PharmD, Partner, Medical & Scientific Affairs Practice Lead, Putnam

Susan Nemetz, Founder & CEO, Corval & The NemetzGroup

Jalpa Shah, Emerging Pharma Medical & Evidence Lead, ZS

Showing Events in 1 Track from 05:15pm to 06:30pm

Networking Reception

5:15PM - 6:15PM

Networking Reception and Silent Auction

6:15PM - 6:30PM

Day One Ends

Showing Events in 1 Track from 08:00am to 08:30am

Day 1 Morning General Session

8:00AM - 8:20AM

Registration Opens

8:20AM - 8:30AM

Co-Chairs Opening Remarks

Co-Chairs:

Anna Frostegård, MD, PhD, Co-Founder, Chief Scientific & Medical Officer, Annexin Pharmaceuticals

Nerissa Kreher, MD, MBA, Consultant CMO/Board Member, Rezolute Bio

Keynote Fireside Discussion: Competitive Strategy & Sustained Innovation in Biotech

Showing Events in 1 Track from 08:30am to 10:00am

Keynotes

8:30AM - 9:00AM

Gary Pisano, PhD, Harry E Figgie, Jr Professor of Business Administration, Harvard Business School

Alex Snyder, MD, EVP, Research and Development, Generate Biomedicines

9:00AM - 9:30AM

R&D Leadership Keynote

Mathai Mammen, MD, PhD, CEO, President, and Chairman, FogPharma

Nerissa Kreher, MD, MBA, Consultant CMO/Board Member, Rezolute Bio

9:30AM - 10:00AM

Biotech Investment Banking Keynote Fireside Discussion with HC Wainwright's Vice Chairman, Head of M&A and Strategic Advisory Services

Michael Meyers, Vice Chairman & Head of M&A and Strategic Advisory Services, HC Wainwright & Co.

Grand Opening Break & Networking

Showing Events in 1 Track from 10:00am to 10:45am

Grand Opening Break & Networking

10:00AM - 10:45AM

Showing Events in 1 Track from 10:45am to 01:00pm

Day 1 Morning General Session Continued

10:45AM - 11:15AM

Veteran Perspectives to Pivoting as a CMO

Anna Frostegård, MD, PhD, Co-Founder, Chief Scientific & Medical Officer, Annexin Pharmaceuticals

Patrick Burnett, MD, PhD, CMO, Arcutis Biotherapeutics

Elliot Ehrich, MD, CMO, EVP, Translational Science, LifeMine Therapeutics

11:15AM - 11:30AM

When a Lethal Disease becomes Chronic: The Emergence of Patient Reported Outcomes in Oncology

Michael Murphy, MD, PhD, CMO / CSO, Worldwide Clinical Trials

11:30AM - 12:00PM

Managing and Motivating a Biotech Team in 2024

Joanne Lager, MD, CMO, NiKang Therapeutics

Donna Higgins, CEO, The Higgins Group

Oscar Segurado, MD, PhD, CMO, ASC Therapeutics

Amy Simon, MD, CMO, Beam Therapeutics

12:00PM - 12:15PM

A Quantitative Framework for Effective Patient-Centric Trial Design in Capital-Limited Environments

Scott Chetham, PhD, CEO and Co-Founder, Faro Health

12:15PM - 12:45PM

How to Create the Greatest Value Within a Budget Before the Next Funding Raise

Alessandra Cesano, MD, PhD, CMO, EVP, ESSA Pharma

Sofia Baig, President, Clinical Solutions, Precision for Medicine

Leonard Dragone, MD, PhD, CMO, Abata Therapeutics

Jeffrey Humphrey, MD, Founder, CEO, Charged Biotherapeutics

12:45PM - 1:00PM

Implement a Lean Methodology for More Efficient Clinical Trial Operations

Julie Martin, MSc, MBA, CEO & Co-Owner, Scimega Research

Showing Events in 1 Track from 01:00pm to 02:00pm

Lunch

1:00PM - 2:00PM

Lunch and Networking

Showing Events in 2 Tracks from 02:00pm to 03:30pm

Track A: Best Practices Managing CMO Departments (Ballroom Foyer)

How CMOs Build a Network of Consultants

Sonal Gupta, MD, PhD, SVP, Head of Clinical Development, AffyImmune Therapeutics

Carrie Brownstein, MD, CMO, CMB BioPharma Solutions LLC

Swaminathan Murugappan, MD, PhD, CMO, Trident Bio Consulting Inc.

Jen Seda, MD, Practice Lead & Senior Vice President, Medical, SSI Strategy

How Biotechs and CROs Navigate their Relationships to Advance Clinical Development

Roger Waltzman, MD, MBA, CMO, Indaptus Therapeutics

Danko Dominis, MD, PhD, VP, Global Medical Officer, Biotech Solutions, PPD, part of Thermo Fisher Scientific

Chuck Gelb, Chief Commercial Officer, Phastar

Judith Ng-Cashin, MD, Chief Medical Officer, Novotech

Edwin Rock, MD, PhD, CMO, GlycoMimetics

Patient Engagement: Practical Approaches

Kali Stasi, MD, PhD, SVP, Clinical Development, Adverum Biotechnologies, Inc.

Arun Balakumaran, MD, PhD, CMO, Replay Bio

Charlotte Guzzo, Co-Founder and COO, Sano Genetics

Wendy Harman, VP Product Marketing, Tasso, Inc.

Jessica Scott, MD, JD, CEO, Legacy Health Strategies

Track B: The Lifecycle of a Biotech CMO (Grand Ballroom)

CEOs’ Insights on Where CMOs can Best Add Value for Companies in Different Stages

James "Terry" Ferguson, MD, CMO, Matinas Biopharma

Laurent Audoly, PhD, Executive Partner, Apollo Health Ventures

Steve Kanes, MD, PhD, CEO, EmbarkNeuro

John Mumm, PhD, President & CEO, DEKA Biosciences

The CMO as a Translational Scientist

Joseph Elassal, MD, MBA, CMO, Ankyra Therapeutics

Panelist:

Steven Katz, MD, CMO, TriSalus Life Sciences

Andrea Wang-Gillam, MD, PhD, CMO, Jacobio Pharmaceuticals

Scaling Up Effectively as Your Biotech Company Evolves

Peter Francis, MD, PhD, CMO & CSO, Ray Therapeutics

Gurdyal Kalsi, MD, CMO, Asklepion Pharmaceuticals

James Lewis, Executive Director, Barrington James

Ajay Sadhwani, SVP of Operations, Harbor Clinical

Hunter Smith, Head of Clinical Recruitment, Govig & Associates

Showing Events in 1 Track from 03:30pm to 04:15pm

Afternoon Break & Networking

3:30PM - 4:15PM

Afternoon Break & Networking

Showing Events in 2 Tracks from 04:15pm to 05:15pm

Track A: Best Practices Managing CMO Departments (Ballroom Foyer)

Maximizing Regulatory Interactions

Simon Cooper, MBBS, CMO, Morphic Therapeutic

Vijay Kasturi, MD, CMO, CG Oncology

Giovanni Selvaggi, MD, CMO, Xcovery Holdings

Mark Sumeray, MD, CMO, Amolyt Pharma

What CMOs Need to Know about Partnering with Hospitals & Clinical Research Sites

Eric Feldman, MD, Director, Early Phase Clinical Trial Program, Montefiore Einstein Comprehensive Cancer Center

Bruce Dezube, MD, CMO, Mustang Bio

Serena Hung, MD, Former CMO, Arkuda Therapeutics

Karen Ivester, RN, MA, Executive Director, Operations, Oncology and Cell & Gene Therapy, inSeption Group

Manoj Malhotra, MD, CMO, Ovid Therapeutics

Track B: The Lifecycle of a Biotech CMO (Grand Ballroom)

Transitioning from Early Stage to Registrational/Pivotal Stage Development

Arvin Yang, MD, PhD, CMO, Pheon Therapeutics

Johan Baeck, MD, Executive Vice President & Chief Medical Officer, Promontory Therapeutics Inc.

Lise Kjems, MD, PhD, CMO, Ocelot Bio

May Orfali, MD, MBA, CMO, Harbinger Health

Preparing for Launch: What CMOs Need to Know and Do

John Yee, MD, MPH, Senior VP, Medical Affairs, Apnimed, Inc.